ON THE IMPORTANCE OF LANCING THE TEETHING INFANT'S GUMS, AS VIEWED IN 1857

PEDIATRICS ◽  
1981 ◽  
Vol 67 (1) ◽  
pp. 135-135
Author(s):  
T. E. C.

John Arbuthnot (1667-1735),1 physician to Queen Anne, claimed that "above a tenth part of Infants die in Teething by Symptoms proceeding from the irritation of the tender parts of the Jaws." He, along with many others, including Ambroise Paré (1510-1590),2 recommended lancing the gums in difficult cases. The same recommendation was found in many American medical journals well into the nineteenth century, as is evident in this quotation published in 1857.3 The principal thing in the treatment of these cases, is to lance the gums freely. A superficial incision will be of no avail; the gums must be cut down until the lancet impinges on the approaching tooth. The only caution required, is that the incision be inclined outwards, in order to avoid the tissues which connect the permanent and temporary teeth. . . . The operation requires considerable skill and caution to ensure its safe and effectual performance. The terrors of the mother and the restlessness of the infant, frequently render it by no means an easy operation; and the careless operator is apt to wound either the cheeks or tongue, to make the incisions too superficially to be of the slightest use. The prejudices of former writers against this invaluable operation scarcely require comment; but as we still find a few, and we are happy to say a very few individuals, who retain a bigoted faith in the absurd dogmata of their forefathers, we will briefly refer to the objections which have been urged against the utility of lancing the gums.

2012 ◽  
Vol 56 (4) ◽  
pp. 463-480 ◽  
Author(s):  
Shinjini Das

AbstractThe historiography of medicine in South Asia often assumes the presence of preordained, homogenous, coherent and clearly-bound medical systems. They also tend to take the existence of a medical ‘mainstream’ for granted. This article argues that the idea of an ‘orthodox’, ‘mainstream’ named allopathy and one of its ‘alternatives’ homoeopathy were co-produced in Bengal. It emphasises the role of the supposed ‘fringe’, ie. homoeopathy, in identifying and organising the ‘orthodoxy’ of the time. The shared market for medicine and print provided a crucial platform where such binary identities such as ‘homoeopaths’ and ‘allopaths’ were constituted and reinforced. This article focuses on a range of polemical writings by physicians in the Bengali print market since the 1860s. Published mostly in late nineteenth-century popular medical journals, these concerned the nature, definition and scope of ‘scientific’ medicine. The article highlights these published disputes and critical correspondence among physicians as instrumental in simultaneously shaping the categories ‘allopathy’ and ‘homoeopathy’ in Bengali print. It unravels how contemporary understandings of race, culture and nationalism informed these medical discussions. It further explores the status of these medical contestations, often self-consciously termed ‘debates’, as an essential contemporary trope in discussing ‘science’ in the vernacular.


2020 ◽  
Vol 7 (01) ◽  
pp. 03-10
Author(s):  
KokWeng Leong ◽  
Tara Dalby ◽  
Lashmi Venkatraghavan

AbstractThis review is a synopsis of selected articles from neuroscience, neuroanesthesia, and neurocritical care from 2019 (January–November 2019). The journals reviewed included anesthesia journals, critical care medicine journals, neurosurgical journals, as well as high-impact medical journals such as the Lancet, Journal of American Medical Association, New England Journal of Medicine, and Stroke. This summary of important articles will serve to update the knowledge of anesthesiologists and other perioperative physicians who provide care to neurosurgical and neurocritical cases.


2016 ◽  
Vol 49 (4) ◽  
pp. 577-600 ◽  
Author(s):  
JOSEPH M. GABRIEL

AbstractThe attitudes of physicians and drug manufacturers in the US toward patenting pharmaceuticals changed dramatically from the mid-nineteenth century to the mid-twentieth. Formerly, physicians and reputable manufacturers argued that pharmaceutical patents prioritized profit over the advancement of medical science. Reputable manufactures refused to patent their goods and most physicians shunned patented products. However, moving into the early twentieth century, physicians and drug manufacturers grew increasingly comfortable with the idea of pharmaceutical patents. In 1912, for example, the American Medical Association dropped the prohibition on physicians holding medical patents. Shifts in wider patenting cultures therefore transformed the ethical sensibilities of physicians.


CJEM ◽  
2020 ◽  
Vol 22 (S1) ◽  
pp. S89-S89
Author(s):  
A. Kirubarajan ◽  
A. Dragoman ◽  
J. Balakumaran ◽  
T. Got ◽  
N. Persaud ◽  
...  

Introduction: The opioid epidemic has been influenced by immense marketing campaigns produced by pharmaceutical companies. These campaigns include advertisements aimed at emergency medicine (EM) physicians, which may have influenced overprescription. This study is a part of a larger effort to systematically assess opioid ads published in major medical journals in North America. To our knowledge, this is the first study to systematically assess the volume, claims, and levels of evidence for opioid ads aimed at EM physicians. Methods: Up to two issues per year from 1996 to 2016 of ten major North American medical journals were hand-searched for opioid advertisements. Specifically, we assessed random samples of issues from five major North American emergency medicine journals, including Annals of Emergency Medicine, Emergency Medicine, Canadian Journal of Emergency Medicine, Emergency Medicine Journal, and American Journal of Emergency Medicine. Five generalist medical journals were assessed including Journal of the American Medical Association, New England Journal of Medicine, Canadian Medical Association Journal, American Family Physician, and Canadian Family Physician. The volume of advertisements, nature of the claims, and cited evidence were collected by independent reviewers. The referenced evidence was assessed using the Oxford Centre for Evidence-Based Medicine Levels of Evidence rubric. Results: Of the 269 issues across the ten journals, opioid ads compromised 95 of the 3392 pharmaceutical advertisements with 79 opioid ads available for analysis. When analysis was completed with two reviewers, inter-rater agreement was rated as 99.87 (Cohen's kappa of 0.976). 37/79 ads did not mention the addictive potential of opioids, with 60/79 not mentioning the possibility of death. The tamper potential of medications was mentioned in 27/79 ads. Positive claims included efficacy (47/79), fast-acting ability (16/79), patient preference (5/79), convenience (26/79) and reduced side effects (22/79). 26/79 cited references directly in their text. Citations were provided for a total of 19 available original studies, of which a majority (16/19) were Level 2 evidence. Upon examination of conflicts of interest, 100% (19/19) of the referenced studies were funded by a pharmaceutical company. Conclusion: A variety of claims were published in medical journals through opioid advertisements, which cite industry studies. Many ads did not mention key negative information, which may have influenced EM physician prescribing.


Sign in / Sign up

Export Citation Format

Share Document